Up to half of U.S. women aged 40 to 74 years have dense breasts, meaning the proportion of fibrous and glandular tissue exceeds that of fatty tissue.
This common inherited trait is associated with elevated risk for breast cancer, and it also can limit the effectiveness of breast cancer screening.
Fatty tissue appears almost black on mammograms. Dense breast tissue appears white — the same color as breast tumors or masses — making it more difficult for radiologists to see cancers and potentially leading to delayed diagnosis.
Nearly three dozen states have passed legislation that requires some level of notification to women determined by mammography to have dense breasts.
However, the type of information in these notices varies greatly.
Some do not include a woman’s breast density category, which indicates the extent of dense tissue. Others do not explain the link between breast density and cancer risk or encourage women with dense breast tissue to discuss supplemental screening strategies with their primary care physician.

Karla Kerlikowske“All women having mammography should know their category of breast density so they or their provider can calculate their breast cancer risk. Simply telling a woman she has dense breasts is not helpful without knowing the category of breast density, which determines risk for breast cancer and missed cancer,” Karla Kerlikowske, MD, professor in the departments of medicine and epidemiology/biostatistics at University of California, San Francisco, told HemOnc Today.

HemOnc Today spoke with radiologists, epidemiologists and other experts about the biologic link between breast density and cancer risk; research efforts to reduce cancer risk among women with dense breasts; the limitations of mammography for this population and the possibility that other screening modalities may be more effective; and the need for standardized notification laws.
Classification and prevalence
The Breast Imaging Reporting and Data System (BI-RADS) — established by American College of Radiology in 1986 — classifies breast tissue into four main density categories:
Category A — almost entirely fatty;
Category B — scattered fibroglandular densities;
Category C — heterogeneously dense; and
Category D — extremely dense.
“Radiologists review screening results and place women in one of these four categories,” Jack Cuzick, PhD, FRS, CBE, director of Wolfson Institute of Preventive Medicine and head of Centre for Cancer Prevention at Queen Mary University of London, told HemOnc Today. “Areas that appear white on film consist of both epithelial cells and fibrous tissue.
“Breast density measures both of these cells, but this is thought to be the best available, albeit indirect, measure of the number of epithelial cells,” Cuzick added. “These are the cells that can divide and become cancer. The more cells a person has that can possibly divide, the greater risk that one of the cells will have a mutation and become a cancer.”
More than 30 million American women fall into the two most extreme breast density categories, according to a study by Sprague and colleagues.
Researchers reviewed data from 1.51 million mammograms conducted from 2007 to 2010 at Breast Cancer Surveillance Consortium facilities.
Results showed 43.3% (95% CI, 43.1-43.4) of women aged 40 to 74 years had heterogeneously dense or extremely dense breasts. The proportion appeared inversely associated with age and BMI.
Investigators estimated that 27.6 million American women aged 40 to 74 years had dense breasts. When researchers included women aged 75 years or older in their analysis, the number reached 30.8 million.
Several factors — including younger age, lower BMI and receipt of hormone therapy for menopause — increase risk for dense breasts. Conversely, two strategies to reduce breast cancer recurrence — tamoxifen for premenopausal women and aromatase inhibitors for postmenopausal women — have been shown to reduce breast density.
However, genetics may explain much of the risk.
In the Healthy Twin study, Sung and colleagues assessed the role of genetic factors on mammographic density measurements among 730 Korean women. The analysis included 122 monozygotic twin pairs, 28 dizygotic twin pairs and 430 first-degree relatives.
The researchers determined the covariance between dense and nondense area had a significant genetic basis (correlation coefficient=– 0.25; standard error=.06).
“The Healthy Twin study showed that, if one identical twin has a certain level of breast density, then the other twin has a very similar level,” Kerlikowske said. “It is even true among fraternal twins, and the same has been found between mothers and daughters.”
Additional research has revealed genes associated with breast density.
For instance, Lindström and colleagues identified common variants in ZNF365 as associated with breast density and breast cancer risk. Later, researchers identified genome-wide significant loci associated with breast density measures, including dense area (AREG, ESR1, ZNF365, LSP1/TNNT3, IGF1, TMEM184B and SGSM3/MKL1), nondense area (8p11.23) and percent density (PRDM6, 8p11.23 and TMEM184B).
“Several studies have shown evidence for familial aggregation of breast density and genes underlying breast density, and several of these genes are also associated with breast cancer,” Celine M. Vachon, PhD, professor of epidemiology and chair of the division of epidemiology at Mayo Clinic in Rochester, Minnesota, told HemOnc Today.
The prevalence of breast density also varies by race and ethnicity.
McCarthy and colleagues determined black women had a higher prevalence of dense breasts than white women, even after adjustments for age, BMI and other breast cancer risk factors.
The researchers evaluated data from 2,845 women (1,589 black and 1,256 white; mean age, 57 years) with no history of breast cancer.
Investigators used a software algorithm developed at their institution to evaluate absolute and percent area density. They used FDA-approved software (Quantra, Hologic) to calculate volumetric estimates of absolute and percent dense tissue.
Results showed black women had significantly higher absolute breast area (40.1 cm2 vs. 33.1 cm2; P<.001 and volume cm3 vs. p than white women. however women had a higher area percent density when researchers adjusted for age bmi cancer risk factors black demonstrated significantly breast in all categories including absolute associations exist between established suggesting these may influence through their on according to vachon. strongest have been observed with vachon said. such as nulliparity are associated increased decreases the more children woman has. boyd colleagues analyzed association mammographic risk. conducted three nested case-control studies screened populations matched pairs. investigators used cumulus semiautomated method measuring examine of measured percentage baseline mammogram findings revealed that at least dense tissue nearly five times greater less ci regardless whether was detected by screening or year after negative examination among aged younger years median cohort cancers half were attributed more. study published this showed elevated linked persists older braithwaite data from surveillance consortium who underwent mammography community practice bi-rads category c d hr="1.39;" ages page break conversely b reduced is composed numbers ductal epithelial cells thus having increases occurrence kerlikowske also an increase collagen fibroblast tissue. hypothesized it proteins secreted not stroma she added. molecule cd36 thought get turned off breasts protected individuals without despite evidence suggests high does mortality those develop other patient tumor characteristics taken into account. gierach examined all-cause within consortium. assess diagnosed primary invasive mean follow-up documented deaths which due cancer. multivariable analyses site diagnosis stage treatment reduction examining approaches aimed reducing breasts. consistently shown decreased oral tamoxifen use clear gel will same effects. university southern california launched randomized double-blind clinical trial bhr-700 healthcare proprietary contains has strong affinity estrogen receptors can effectively reduce healthy years. binds stopping cell cycle induced estradiol researcher pulin a. sheth md assistant professor radiology director imaging norris center school medicine usc. interference prevent proliferating cells. patients receive two actuations per containing total mg bhr-700. matching placebo. participants be treated they choose another active open-label fashion. determined standard digital serve outcome measure. tolerability safety monitored blood levels circulating measured. hope find there statistically significant clinically meaningful told hemonc today. overall focuses very we hopeful effect could larger. notification laws early october states adopted require some type mammograms. meant raise awareness receiving providers result better understanding limitations well options available them should see her doctor new symptoms. tremendous variation laws. everyone letter whereas others only found heterogeneously extremely degree actionable information importance discussing supplemental care physician differs greatly. federal lawmakers began introducing legislation congress standardize process. goal ensure notifications educate about explain how mask presence encourage talk health screening. tried bill passed but still most want know favor concept letters randy c. miles mph radiologist division massachusetts general hospital. mph. need evaluate best issue he highly variable across states. david z. chow. law requires notify writing if results show assessed knowledge routine passage law. administered surveys academic medical during periods. responded. surprised unaware newly enacted legislation. n="185)" respondents reported group correctly implementation state since confusion misinformation wrote. christine m. gunn phd research boston affected perceptions participation care. phone interviews english-speaking received interviewed recalled notification. remember specific content many indicated struggled interpret what meant. majority planned did physicians previous analysis readability ranged seventh-grade college levels. tend written literacy level difficulty prepared communication shows alone do sufficiently exactly is. coupling being able counsel topic create lot confusion. modality u.s. accurate creating potential overlooked false-positive additional follow-up. offer benefits disadvantages too. costs consider procedures risks false positives workup anxiety. job stratifying both molecular ability detect missed conventional approach few centers. mri often complement costly. tomosynthesis called number compared traditional while unnecessary recall rates. becoming practices radiologists time approach. costlier exposed doses radiation. preventive services task force guideline includes section no formal guidance insufficient balance harms adjunctive using ultrasonography methods identified otherwise improve detection evidence-based necessary fast-moving target confused ultrasound mri. largely variability recommendations country. hospital recommend high-quality based existing perform whole-breast discuss personal developing determine meet criteria anxiety feel hear calmed develops consistent guidelines considerable underway compare modalities under development groups working liquid biopsy tests shedding noninvasive test especially automated technique provides volumetric entire combination alone. south korea every receives adjunct test. resistance united provide because takes promising so maybe technology continue disseminates practice. reproducible handheld ultrasound. advantages: radiation exposure compressed relatively quick reese videssa diagnostics combinatorial proteomic biomarker assay comprised serum protein biomarkers tumor-associated autoantibodies patient-specific yields diagnostic score reliably detects making potentially viable tool evaluated included whom sensitivity specificity nondense predictive values appear impacted density. alike powerful present challenging findings. personalized experts today spoke supported cannot upon full assessment needs performed accounting family history body mass index several tools take lifestyle account estimate lifetime low benefit accompanied its own set costs. beneficial. cuzick addressed risk-adaptive highest considered therapy premenopausal aromatase inhibitor postmenopausal idea renaming program prevention try identify ways one exciting areas field. jennifer southall click here read valid references: nf et al. engl j med. epidemiol prev. ghosh k clin oncol. gl natl inst. cm educ couns. lee med north am. lindstr s nat commun. doi:10.1038 genet. mccarthy am abstract presented at: american annual meeting april philadelphia. rc acad radiol. de plos one. siu al ann intern sprague bl sung res treat. zhang information: jack frs cbe reached wolfson institute queen mary london charterhouse square ec1m kingdom email: j.cuzick e. concord st. ma cgunn karla san francisco vamc ca karla.kerlikowske fruit randy.miles twitter: keck usc zonal ave. los angeles pulin.sheth celine mayo clinic sw rochester mn vachon.celine disclosures: report relevant financial disclosures.>Original Article can be found by clicking here